BCVPP CHEMOTHERAPY FOR ADVANCED HODGKINS-DISEASE - EVIDENCE FOR GREATER DURATION OF COMPLETE REMISSION, GREATER SURVIVAL, AND LESS TOXICITY THAN WITH A MOPP REGIMEN

被引：89

作者：

BAKEMEIER, RF

ANDERSON, JR

COSTELLO, W

ROSNER, G

HORTON, J

GLICK, JH

HINES, JD

BERARD, CW

DEVITA, VT

机构：

[1] SIDNEY FARBER CANC INST, BOSTON, MA 02115 USA

[2] UNION UNIV ALBANY MED COLL, ALBANY, NY 12208 USA

[3] HOSP UNIV PENN, PHILADELPHIA, PA 19104 USA

[4] CASE WESTERN RESERVE UNIV, CLEVELAND, OH 44106 USA

[5] ST JUDE CHILDRENS RES HOSP, MEMPHIS, TN 38101 USA

[6] NCI, BETHESDA, MD 20205 USA

来源：

关键词：

D O I：

10.7326/0003-4819-101-4-447

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：447 / 456

页数：10

共 59 条

[1] ABRAMS RA, 1981, CANCER RES, V41, P35
[2] BAKEMEIE.RF, 1974, P AM ASSOC CANC RES, V15, P183
[3] BAKEMEIER RF, 1979, P AM ASSOC CANC RES, V20, P392
[4] BAKEMEIER RF, 1978, PROGR CANCER RES THE, V6, P513
[5] BAKEMEIER RF, 1976, P AN M AM SOC CLIN, V17, P225
[6] BAKEMEIER RF, 1982, P AN M AM SOC CLIN, V1, P164
[7] BENNETT JM, 1976, CANCER TREAT REP, V60, P739
[8] BLOOMFIELD CD, 1982, CANCER TREAT REP, V66, P835
[9] BONADONNA G, 1975, CANCER, V36, P252, DOI 10.1002/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO
[10] 2-7